Research News
UMass Chan clinical trial shows antisense oligonucleotide safely suppresses mutant ALS gene in pilot human study
Read more
The NeuroNexus Institute at UMass Medical School
Nexus: a connection, hub or junction, a connected group or series, the center or focus.
- The NeuroNexus Institute at UMass Medical School brings together basic scientists, clinicians and trainees with the goal of understanding nervous system function and dysfunction, leading to improved diagnosis and treatment of neurological, neurodevelopmental and psychiatric disorders.
- Institute faculty also teach, supervise and mentor the next generation of academic and industry leaders, medical practitioners and educators.
- Our community also reaches out to increase public awareness of nervous system function and diseases, of fact-based scientific investigation, and to reduce the stigma of neurological and psychiatric disorders.
- Please explore these pages to learn more about our people, projects and progress.
Our Mission: From Discoveries to Therapies
The mission of the NeuroNexus Institute at UMass Medical School is to catalyze interactions between basic scientists and translational or clinician scientists, forming interdisciplinary teams that tackle innovative projects, achieve breakthroughs in basic neuroscience knowledge, and accelerate development and implementation of innovative therapies to treat neurological conditions.
Our Vision
To integrate our extensive local community of basic and clinical neuroscientists into a hub of interactions, leading to innovation, discovery and development of new treatments for neurological disorders, and attract diverse funding sources.
Our Approach
- Understand principles of nervous system physiology
- Leverage these principles of neuroscience to understand disease mechanisms
- Accelerate treatments
- Educate future generations of academic leaders and medical practitioners
- Impact patient care
- Reach out and Educate the public of the Commonwealth of Massachusetts and beyond
News
Getting Results…
-
![UMass Chan clinical trial shows antisense oligonucleotide safely suppresses mutant ALS gene in pilot human study]()
-
![Sio Gene Therapies reports positive interim data for gene therapy trial]()
Research NewsSio Gene Therapies reports positive interim data for gene therapy trial
Read more -
![Riaan Research Initiative funds Cockayne syndrome gene replacement therapy research at UMass Chan Medical School]()
Research NewsRiaan Research Initiative funds Cockayne syndrome gene replacement therapy research at UMass Chan Medical School
Read more -
![Two new studies from Daryl Bosco lab shed new light on ALS mechanisms]()
Research NewsTwo new studies from Daryl Bosco lab shed new light on ALS mechanisms
Read more
